Experience

Laura Berezin

    • Ovid - $75 Million IPO 


    • ALX Oncology – $186 Million IPO 


    • Vir Biotechnology - $143 Million IPO 


    • Applied Therapeutics $40 Million IPO 


    • Immune Design Sale to Merck for $300 Million 


    • Harpoon Therapeutics - $76 Million IPO 


    • Kezar Life Sciences – $86 Million IPO